Bottiroli, Sara
Rosi, Alessia
Sances, Grazia
Allena, Marta
De Icco, Roberto
Lecce, Serena
Vecchi, Tomaso
Tassorelli, Cristina
Cavallini, Elena
Article History
Received: 22 March 2023
Accepted: 13 April 2023
First Online: 28 April 2023
Declarations
:
: The study was performed in accordance with the guidelines of the Declaration of Helsinki. Authors obtained local ethics committee (San Matteo Hospital, Pavia, Italy—reference code p-20170016073) approval of the protocol. All patients provided written informed consent in advance of study participation.
: Not applicable.
: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: CT received honoraria for the participation in advisory boards or for lecturing from: Allergan, Eli-Lilly, Novartis, and Teva. CT and GS has no ownership interest and does not own stocks of any pharmaceutical company. CT is on the editorial board of The Journal of Headache and Pain. GS received honoraria for the participation in advisory boards or for lecturing from: Eli-Lilly, Novartis, and Teva. The remaining authors have no conflicts of interest.